Morpholine-4-carboximidamide hydrochloride, 95.0%, 250mg

4-bromo-3-fluoro-2'-(3-pyrrolinomethyl) benzophenone, 97.0%, 1g

3,4-Dihydroxybenzaldehyde, min. 98%, 100 g, plastic packaging.

Methyl 4-(3-methyloxiran-2-yl)benzoate, 250mg

5-Aminovaleric Acid Hydroiodide>97.0%(N)(T)1g

4-(4'-Methyl-[2,2'-bipyridin]-4-yl)butanoic acid, 95.0%, 1g

3-PYRROLIDINEACETIC ACID HCL, 97.0%, 1g

5-Methoxyindole, min. 98%, for synthesis, 5 g, glass packaging

2-Bromo-4,5-difluorotoluene>98.0%(GC)5g

5-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoxazole, 95.0%, 1g

l-Leucine methyl ester hydrochloride, 98.0%, 100g

(4R,4'R)-2,2'-(2,3-Dihydro-1H-indene-2,2-diyl)bis(4-(tert-butyl)-4,5-dihydrooxazole), 97%, 250mg

7-chloro-5-nitro-1H-indazole, 97%, 1g